TIRUMALCHMNSEThirumalai Chemicals Limited· Chemicals - OrganicLowNeutral
Announced Thu, 26 Jun · 15:51 IST

Thirumalai Chemicals Limited has informed the Exchange that 52nd Annual General Meeting of the Company will be held on Friday, July 25, 2025 at 2.30 p.m through Video Conferencing ( VC )/Other Audio Visual Means ( OAVM ).

Board & Shareholder Meetings View source PDF

TIRUMALCHM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Thirumalai Chemicals Limited has notified that its 52nd Annual General Meeting will be held on Friday, July 25, 2025 at 2:30 p.m. through Video Conferencing (VC)/Other Audio Visual Means (OAVM). The register of members and share transfer books will remain closed from July 19, 2025 to July 25, 2025, with the e-voting window open from July 21 (3:00 p.m.) to July 24, 2025 (5:00 p.m.) and a cut-off date of July 18, 2025. Ordinary business items include adoption of audited financial statements for FY ending March 31, 2025 and re-appointment of Mr. R. Sampath as a Director (retiring by rotation), a promoter holding 29,50,155 shares. Special business items include the re-appointment of Mr. R. Parthasarathy as Chairman and Managing Director for three years (August 1, 2025 to July 31, 2028) with a basic salary of ₹21 lakh/month rising by ₹2.5 lakh annually plus up to 3% commission on net profits, re-appointment of Mrs. Bhama Krishnamurthy as Independent Director for four years, and appointment of Mrs. D. Sabitha, Mr. Meghav Mehta (both as Independent Directors for five years) and Mr. Raj Kataria as a Non-Executive Director. The notice also seeks approval to appoint M/s. R.M. Mimani & Associates LLP as Secretarial Auditors for five years (FY 2025-26 to FY 2029-30) and ratify the appointment of M/s GSVK & Co. as Cost Auditor for FY 2025-26 at a fee of ₹1 lakh.

Likely market impact

Routine AGM intimation with key items requiring shareholder approval: continuation of the existing Chairman & Managing Director with a defined remuneration structure and the addition of three new directors to the board. Special resolutions for MD re-appointment and director inductions may draw attention but no major operational or financial changes are signalled.